2018
DOI: 10.1158/0008-5472.can-18-1416
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures

Abstract: Invasive lobular carcinoma (ILC) is the second most common subtype of breast cancer following invasive ductal carcinoma (IDC) and characterized by the loss of E-cadherin-mediated adherens junctions. Despite displaying unique histologic and clinical features, ILC still remains a chronically understudied disease, with limited knowledge gleaned from available laboratory research models. Here we report a comprehensive 2D and 3D phenotypic characterization of four estrogen receptor-positive human ILC cell lines: MD… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

12
76
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 60 publications
(91 citation statements)
references
References 56 publications
12
76
2
Order By: Relevance
“…Consistent with clinical observations, we identified tamoxifen-resistance in ER-positive ILC models, including de novo ER partial agonism by anti-estrogens [13,14]. These data raise the question of whether ER function and signaling is unique in the context of ILC.…”
Section: Introductionsupporting
confidence: 83%
“…Consistent with clinical observations, we identified tamoxifen-resistance in ER-positive ILC models, including de novo ER partial agonism by anti-estrogens [13,14]. These data raise the question of whether ER function and signaling is unique in the context of ILC.…”
Section: Introductionsupporting
confidence: 83%
“…SUM44PE (SUM44) cells were purchased from Asterand and BCK4 cells were kindly provided by Britta Jacobsen, University of Colorado Anschutz, CO. Cell lines were maintained as previously described [23] in the following media (Life Technologies) with 10% FBS: MDA-MB-134 and MDA-MB-330 in 1:1 DMEM:L-15, MCF7 and MDA-MB-231 in DMEM, T47D in RPMI, BCK4 in MEM with non-essential amino acids (Life Technologies) and insulin (Sigma-Aldrich). SUM44 cells were maintained as described [25] in DMEM-F12 with 2% charcoal stripped serum and supplements.…”
Section: Methodsmentioning
confidence: 99%
“…2D and ULA growth assays were performed as previously described [23]. ILC (15,000/96-well; 300,000/6-well) and IDC (5,000/96-well; 100,000/6-well) cells were seeded in regular (Thermo Fisher Scientific) or ULA (Corning Life Sciences) 96-well plates.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations